HTA Council Recommendation (as of 18 June 2025) The HTA Council positively recommends the government financing of HIV/Syphilis Duo Test for screening of HIV and Syphilis infection in pregnant women as part of antenatal care, ideally during the first trimester The HTA Council strongly recommends that implementation of HIV health technologies should follow the WHO continue reading : HIV/Syphilis Duo Test for screening of HIV and Syphilis infection in pregnant women as part of antenatal care, ideally during the first trimester
HIV Self Test Kit for screening of HIV infection in adults belonging to HIV and sexually transmitted infection key populations
HTA Council Recommendation (as of 18 June 2025) The HTA Council positively recommends the government financing of HIV Self Test Kit for screening of HIV infection in adults belonging to HIV and sexually transmitted infection key populations*. The HTA Council strongly recommends that implementation of HIV health technologies should follow the WHO testing strategy for continue reading : HIV Self Test Kit for screening of HIV infection in adults belonging to HIV and sexually transmitted infection key populations
Lateral flow urine lipoarabinomannan assay (LF-LAM) for diagnosis of active tuberculosis infection in human immunodeficiency virus (HIV) patient
HTA Council Recommendation (as of 9 July 2025) The HTA Council positively recommends the government financing of Lateral flow urine lipoarabinomannan assay (LF-LAM) for diagnosis of active tuberculosis infection in human immunodeficiency virus (HIV) patient The HTA Council recommends that the Department of Health refer to existing and future WHO target product profiles (TPPs) when continue reading : Lateral flow urine lipoarabinomannan assay (LF-LAM) for diagnosis of active tuberculosis infection in human immunodeficiency virus (HIV) patient
Cartridge-based Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) Test for diagnosis of extensively drug-resistant tuberculosis (XDR-TB)
HTA Council Recommendation (as of 9 July 2025) The HTA Council positively recommends the government financing of Cartridge-based Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) Test for diagnosis of extensively drug-resistant tuberculosis (XDR-TB) The HTA Council recommends that the Department of Health refer to existing and future WHO target product profiles (TPPs) when selecting tests for procurement. continue reading : Cartridge-based Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) Test for diagnosis of extensively drug-resistant tuberculosis (XDR-TB)
Line Probe Assay (LPA) for diagnosis of extensively drug-resistant tuberculosis (XDR-TB)
HTA Council Recommendation (as of 09 July 2025) The HTA Council positively recommends the government financing of Line Probe Assay (LPA) for diagnosis of extensively drug-resistant tuberculosis (XDR-TB). The HTA Council recommends that the Department of Health refer to existing and future WHO target product profiles (TPPs) when selecting tests for procurement. In the absence continue reading : Line Probe Assay (LPA) for diagnosis of extensively drug-resistant tuberculosis (XDR-TB)